| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Outline of Final Research Achievements |
We have obtained the histological sample of pancreatic cancer using Endoscopic ultrasonography-fine needle aspiration (EUS-FNA) and continued to make the genetic profile. The evaluation of expression of the marker associated with stem cells related pancreatic cancer was performed. However, we could not detect these markers. Since one of the causes not to detect these markers is that the amount of histological sample by EUS-FNA is very small, we continue to evaluate these markers using the histological samples acquired by operation. Furthermore, sensitivity test of anti cancer drug for pancreatic caner using histological sample acquired by EUS-FNA has been continued. We have compared the clinical information and surgical stage. The cell lines of resistance for anti-cancer drug were used for checking the genetic profile.
|
